Evidence map›Paper›PMID 32219101›Full record

ReviewFrontiers in veterinary science2020

Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases.

Brett D Story, Matthew E Miller, Allison M Bradbury, Emily D Million, Dongsheng Duan, Toloo Taghian, Dominik Faissler, Deborah Fernau, Sidney J Beecy, Heather L Gray-Edwards

Abstract readReview
In one paragraph

Review in Frontiers in veterinary science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. The value of case reports.Frontiers in veterinary science · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. L-Cells · 2021
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brett D StoryAuburn University College of Veterinary Medicine, Auburn, AL, United States.
Matthew E MillerAuburn University College of Veterinary Medicine, Auburn, AL, United States.
Allison M BradburyDepartment of Clinical Sciences and Advanced Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Emily D MillionDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, United States.
Dongsheng DuanDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, United States.
Toloo TaghianHorae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States.
Dominik FaisslerCummings School of Veterinary Medicine at Tufts University, North Grafton, MA, United States.
Deborah FernauHorae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States.
Sidney J BeecyHorae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States.
Heather L Gray-EdwardsHorae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, United States.

Funding

Whole body single AAV microgene therapy in canine DMDR01NS090634 · NINDS · UNIVERSITY OF MISSOURI-COLUMBIA · PI Dongsheng Duan · 2015 to 2026
$4.2M
Treatment of Duchenne Muscular Dystrophy with the Muscle Calcium PumpR01AR070517 · NIAMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI DUAN, DONGSHENG · 2016 to 2020
$3.1M
NIAMS NIH HHS R01 AR070517NINDS NIH HHS R01 NS090634
6 · The paper itself

Abstract

Mouse models of human disease remain the bread and butter of modern biology and therapeutic discovery. Nonetheless, more often than not mouse models do not reproduce the pathophysiology of the human conditions they are designed to mimic. Naturally occurring large animal models have predominantly been found in companion animals or livestock because of their emotional or economic value to modern society and, unlike mice, often recapitulate the human disease state. In particular, numerous models have been discovered in dogs and have a fundamental role in bridging proof of concept studies in mice to human clinical trials. The present article is a review that highlights current canine models of human diseases, including Alzheimer's disease, degenerative myelopathy, neuronal ceroid lipofuscinosis, globoid cell leukodystrophy, Duchenne muscular dystrophy, mucopolysaccharidosis, and fucosidosis. The goal of the review is to discuss canine and human neurodegenerative pathophysiologic similarities, introduce the animal models, and shed light on the ability of canine models to facilitate current and future treatment trials.

Indexed as

caninegene therapylarge animal modelneurodegenerationtranslational

Identifiers

PMID32219101
PMCPMC7078110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.